KLOW Blend
BPC-157 / TB-500 / GHK-Cu / KPV
Four-peptide compounded stack adding anti-inflammatory KPV; no clinical data on the combination.
Not FDA-approved. Compounded combination; not approved. This page describes research and public discussion; it is not a recommendation to use.
Overview
Extends the Glow blend with KPV, an α-MSH fragment with anti-inflammatory activity in animal colitis models.
Mechanism of action
See components.
Benefits & evidence ratings
Dosing
Doses show what has been studied or discussed — not guidance. Always follow your prescriber.
| Source | Dose | Frequency | Duration | Route |
|---|---|---|---|---|
Online / clinic protocols D Anecdotal / community Not derived from controlled human trials. Reported for transparency, not recommendation. | Varies by product | Daily | 4–8 weeks | Subcutaneous |
Clinical trials & studies
No studies of this specific combination have been published.
Safety
Side effects
- Injection-site reactions
- Unknown systemic effects
Contraindications
- Cancer history
- Pregnancy
Interactions
- Unknown
Long-term safety
Unknown.
Regulatory status
Unapproved / research
Compounded combination; not approved.